Loading issuer details...
Rua Bioscience Limited board of directors
5 current directors, 40% independent, average tenure 5.1 years.
| Director | Role | Independent | Appointed | Tenure | Committees |
|---|---|---|---|---|---|
| Anna Stove | Chair | No | 2019 | 7.5 yrs | — |
| Antony (Tony) George Barclay | Independent Director | Yes | 2023 | 3.5 yrs | — |
| Panapa Ehau | Non-Independent Director | No | 2017 | 9.1 yrs | — |
| Paul Naske | Executive Director | No | 2025 | 1.0 yrs | — |
| Teresa Ciprian | Independent Director | Yes | 2022 | 4.3 yrs | — |
RUA governance score breakdown
Rua Bioscience Limited scores 79/100 (Very Good) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.
- Board structure
- 18/25
- Shareholder rights
- 20/20
- Executive remuneration
- 5/10
Rua Bioscience Limited largest shareholders
Top 10 registered holders of RUA as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.
| # | Holder | Holding |
|---|---|---|
| 1 | NEW ZEALAND DEPOSITORY NOMINEE LIMITED <A/C 1 CASH ACCOUNT> | 17.63% |
| 2 | FANG GROUP INVESTMENT LIMITED | 10.55% |
| 3 | GOUGH INVESTMENT CAPITAL LIMITED | 5.69% |
| 4 | HIKURANGI ENTERPRISES LIMITED | 4.71% |
| 5 | ACCIDENT COMPENSATION CORPORATION - NZCSD <ACCI40> | 3.78% |
| 6 | BEENA HARSHAVARDHAN JOG | 3.15% |
| 7 | FNZ CUSTODIANS LIMITED <DTA NON RESIDENT A/C> | 3.03% |
| 8 | GREG ANTONY ANDERSON & NICOLA MARIE ANDERSON <THE ORANGE A/C> | 2.93% |
| 9 | BEVERLEY IDA EVANS | 2.24% |
| 10 | RIDINGS BROTHERS LIMITED | 2.01% |
Recent RUA NZX announcements
The 10 most recent filings by Rua Bioscience Limited to the NZX.
- Ongoing Disclosure Notice - Teresa CiprianInsider Disclosure
- Ongoing Disclosure Notice - Anna StoveInsider Disclosure
- Ongoing Disclosure Notice - Antony BarclayInsider Disclosure
- Ongoing Disclosure Notice - Panapa EhauInsider Disclosure
- Capital Change NoticeCapital Change
- Rua Bioscience ASM Presentation and CommentaryAGM
- Results of 2026 Annual Shareholders' MeetingAGM
- Results of Capital RaiseCapital Raise
- Rua partners with Curaleaf Laboratories for UK distributionOperational Update
- Rua partners to supply medicinal MDMA in New ZealandOperational Update
Rua Bioscience Limited (RUA) — frequently asked questions
What does Rua Bioscience Limited do?
Rua Bioscience is a Maori-owned medicinal cannabis company cultivating, manufacturing, and exporting pharmaceutical-grade cannabis products from Gisborne. Rua Bioscience Limited is listed on the NZX under the ticker RUA, in the Healthcare sector.
What is the Rua Bioscience Limited (RUA) share price?
Rua Bioscience Limited (NZX:RUA) shares closed at $0.026 on 11 November 2026, unchanged on the previous close. At that price its market capitalisation was about $12 million, based on 452,400,000 shares on issue as at 30 September 2026.
Who are the directors of Rua Bioscience Limited?
Rua Bioscience Limited has 5 current directors: Anna Stove (Chair), Antony (Tony) George Barclay (Independent Director), Panapa Ehau (Non-Independent Director), Paul Naske (Executive Director) and Teresa Ciprian (Independent Director). 2 of the 5 are recorded as independent (40%). Average board tenure is 5.1 years.
Who is the chair of Rua Bioscience Limited?
Anna Stove chairs the Rua Bioscience Limited board, and has been a director since 2019.
Who is the CEO of Rua Bioscience Limited?
Paul Naske is the Chief Executive Officer of Rua Bioscience Limited.
Who are the largest shareholders of Rua Bioscience Limited?
The largest registered holder of RUA shares in the FY2025 top-20 register was NEW ZEALAND DEPOSITORY NOMINEE LIMITED <A/C 1 CASH ACCOUNT>, with 17.63%, followed by FANG GROUP INVESTMENT LIMITED (10.55%) and GOUGH INVESTMENT CAPITAL LIMITED (5.69%). Custodians and nominees on the register hold shares on behalf of other investors.
What is Rua Bioscience Limited's governance score?
Rua Bioscience Limited has an NZXplorer Governance Risk Score of 79/100 (Very Good) for FY2026, based on 73% data coverage.
When was the last Rua Bioscience Limited annual meeting?
The most recent Rua Bioscience Limited annual meeting on record was held on 20 October 2026.
Healthcare companies on the NZX
Compare Rua Bioscience Limited with other NZX-listed healthcare companies.